2026年2月初めにアベナ保健医療課の幹部は,株式が高値で上昇した際,5.4-5-550万ドルを株に売却した. In early February 2026, Aveanna Healthcare executives sold $5.4–5.5 million in stock as shares rose on high volume.

2026年2月上旬,CFO Matthew Buckhalter,CAO Deborah Stewart,エグゼクティブ Edwin Reiszを含む複数のAveanna Healthcareのインサイダーが,合計740,000株を売却し,約540万円を稼ぎました. In early February 2026, multiple Aveanna Healthcare insiders, including CFO Matthew Buckhalter, CAO Deborah Stewart, and executive Edwin Reisz, sold a combined 740,000 shares, generating about $5.4–$5.5 million. 2月17日から19日にかけて,価格が7.21から8.36までの交替があった. Transactions occurred between February 17 and 19, with prices ranging from $7.21 to $8.36. 株価は2月20日に7.42ドルで閉店し,大幅な増加でわずかに上昇した. The stock closed at $7.42 on February 20, up slightly, on significantly elevated volume. 家庭医療サービスを提供する同社は,市場額は155億米ドルで,アナリストの評価は"Hold"で,52週間の範囲は3.67ドルから10.32ドルです. The company, which provides in-home health services, has a market cap of $1.55 billion, a "Hold" analyst rating, and a 52-week range of $3.67 to $10.32. 企業の投資家は87.96%の株式を保有しており,目立たない利息を保有している. Institutional investors own 87.96% of shares, with no notable short interest.